• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

Salivary Metabolomics As Markers Of Progression, Prognosis And Effectiveness Of Therapy In Oral Leukoplakia And Oral Cancer: A Review

    Usha Adiga

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 9061-9067

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The overall goal of the review is to discuss about establishing a panel of salivary metabolomics markers which may be useful as a non-invasive prognostic markers of oral precancerous and cancerous conditions. The non-invasive panel of salivary metabolomics may be unique in predicting the prognosis of oral pre-cancer and cancerous states, progression of the disease states as well as the effectiveness of treatment. A future researchstudy may be planned to develop a panel of salivary metabolomics for predicting the prognosis of oral leukoplakia as well as oral cancer. It may also predict association of salivary metabolomics with the treatment effectiveness oral cancer.
A non-invasive and cost-effective salivary metabolomic parameters may be developed for predicting the prognosis of oral leukoplakia and oral cancer. Sensitivity, specificity and predictive values of salivary metabolomics panel may be compared as routine histopathology in predicting the transformation of precancerous to cancer may be established
Keywords:
    metabolomics saliva leukoplakia Oral cancer
  • PDF (203 K)
  • XML
(2023). Salivary Metabolomics As Markers Of Progression, Prognosis And Effectiveness Of Therapy In Oral Leukoplakia And Oral Cancer: A Review. European Journal of Molecular & Clinical Medicine, 9(7), 9061-9067.
Usha Adiga. "Salivary Metabolomics As Markers Of Progression, Prognosis And Effectiveness Of Therapy In Oral Leukoplakia And Oral Cancer: A Review". European Journal of Molecular & Clinical Medicine, 9, 7, 2023, 9061-9067.
(2023). 'Salivary Metabolomics As Markers Of Progression, Prognosis And Effectiveness Of Therapy In Oral Leukoplakia And Oral Cancer: A Review', European Journal of Molecular & Clinical Medicine, 9(7), pp. 9061-9067.
Salivary Metabolomics As Markers Of Progression, Prognosis And Effectiveness Of Therapy In Oral Leukoplakia And Oral Cancer: A Review. European Journal of Molecular & Clinical Medicine, 2023; 9(7): 9061-9067.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 7
  • PDF Download: 29
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus